Ruchi Bansal is an Assistant Professor at University of Twente (Netherlands). She obtained her Bachelor’s and Master’s degree in Biochemistry from Delhi University, India. In 2012, she obtained her PhD from Pharmacokinetics, Toxicology and Targeting, University of Groningen (Netherlands). Her PhD project was focused on designing novel strategies to target interferon gamma and its signaling domain to the target pathogenic cells in the chronic diseases (liver fibrosis and cancer). During the last stages of her PhD, she received two prestigious grants Sheila Sherlock research fellowship (from European association for the study of liver diseases, EASL) and The Ruth and Richard Julin’s Foundation Swedish research grant for postdoctoral research at Karolinska Institute (Stockholm, Sweden). Her research project was focused on “Pathogenesis of Hepatitis C virus (HCV)-induced and alcohol-induced liver diseases”. In October 2012, she started as a senior postdoctoral researcher at the Department of Biomaterials Science and Technology at University of Twente. In 2014, she received a prestigious VENI grant (from NWO, ZonMw) to pursue her research on “Development of novel targeted nano-therapeutics for the treatment of liver diseases”. She has received several awards/honors for her pioneering work and several research grants for pursuing her research. Ruchi has established her independent research team on Liver diseases: from pathogenesis to nanotherapeutics at the University of Twente. She is also a faculty council member and a young academy member at University of Twente. Ruchi aim to translate basic science to clinical advancements by developing emerging diagnostics and targeted therapeutics against liver diseases.